U.S Physical Therapy Total Long Term Liabilities 2010-2024 | USPH

U.S Physical Therapy total long term liabilities from 2010 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.
U.S Physical Therapy Annual Total Long Term Liabilities
(Millions of US $)
2023 $418
2022 $456
2021 $369
2020 $223
2019 $259
2018 $184
2017 $173
2016 $138
2015 $112
2014 $52
2013 $50
2012 $21
2011 $25
2010 $10
2009 $4
U.S Physical Therapy Quarterly Total Long Term Liabilities
(Millions of US $)
2024-06-30 $430
2024-03-31 $433
2023-12-31 $418
2023-09-30 $434
2023-06-30 $424
2023-03-31 $458
2022-12-31 $456
2022-09-30 $400
2022-06-30 $402
2022-03-31 $373
2021-12-31 $369
2021-09-30 $258
2021-06-30 $263
2021-03-31 $230
2020-12-31 $223
2020-09-30 $216
2020-06-30 $241
2020-03-31 $330
2019-12-31 $259
2019-09-30 $265
2019-06-30 $269
2019-03-31 $233
2018-12-31 $184
2018-09-30 $195
2018-06-30 $186
2018-03-31 $164
2017-12-31 $173
2017-09-30 $175
2017-06-30 $186
2017-03-31 $161
2016-12-31 $138
2016-09-30 $65
2016-06-30 $70
2016-03-31 $78
2015-12-31 $112
2015-09-30 $69
2015-06-30 $65
2015-03-31 $60
2014-12-31 $52
2014-09-30 $63
2014-06-30 $54
2014-03-31 $55
2013-12-31 $50
2013-09-30 $16
2013-06-30 $18
2013-03-31 $23
2012-12-31 $21
2012-09-30 $19
2012-06-30 $22
2012-03-31 $26
2011-12-31 $25
2011-09-30 $28
2011-06-30 $18
2011-03-31 $6
2010-12-31 $10
2010-09-30 $5
2010-06-30 $8
2010-03-31 $15
2009-12-31 $4
2009-09-30 $6
2009-06-30 $14
2009-03-31 $17
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $1.274B $0.605B
U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.379B 12.93
Quest Diagnostics (DGX) United States $17.308B 17.75
DaVita (DVA) United States $13.689B 16.84
Encompass Health (EHC) United States $9.303B 22.88
Chemed (CHE) United States $8.694B 26.73
Elanco Animal Health (ELAN) United States $7.242B 16.28
Option Care Health (OPCH) United States $5.321B 26.14
RadNet (RDNT) United States $4.963B 117.74
Amedisys (AMED) United States $3.181B 22.75
Astrana Health (ASTH) United States $2.805B 39.69
LifeStance Health (LFST) United States $2.579B 0.00
Addus HomeCare (ADUS) United States $2.399B 29.12
Pennant (PNTG) United States $1.057B 50.71
Aveanna Healthcare Holdings (AVAH) United States $1.022B 0.00
Atai Life Sciences (ATAI) Germany $0.208B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.025B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.019B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Ontrak (OTRK) United States $0.010B 0.00
Novo Integrated Sciences (NVOS) United States $0.006B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00